Academician
PEYDA KORHAN
DOKTOR ÖĞRETİM ÜYESİ
İZMİR TINAZTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyoloji
Article counts come from two sources, each shown separately: YÖKSİS (academic declarations) and OpenAlex (open scholarly catalog). Patents and artistic activities are listed under the Works tabs below.
Index quartiles
Scopus (SJR)
4 Total
- Q1 3
- Q2 0
- Q3 1
- Q4 0
Other counts
- Excluding abstracts 3 Q1 2 Q2 0 Q3 1 Q4 0
- YÖKSİS rows 4 Q1 0 Q2 0 Q3 0 Q4 0
WoS (JCR)
4 Total
- Q1 1
- Q2 2
- Q3 0
- Q4 1
Other counts
- Excluding abstracts 3 Q1 0 Q2 2 Q3 0 Q4 1
- YÖKSİS rows 4 Q1 0 Q2 0 Q3 0 Q4 0
TR Index
0 articles
OpenAlex citation percentiles
Top 1% articles
0
Top 10% articles
1
Avg percentile
71.2%
Articles with percentile
3
OpenAlex citation percentile; covered works only (~52%).
What do these indicators mean?
- Q1–Q4: the quartile of the journal in the given index (Scopus/WoS). Q1 = top 25%, Q4 = bottom 25%.
- Top 1% / top 10%: number of works among the top 1% or 10% most-cited worldwide in the same field and year.
- Avg percentile: mean citation percentile of the works (100 = highest).
- Source: index quartiles from Scopus/WoS and TR Index flags; citation percentiles from OpenAlex.
Proceedings
Conference proceedings recorded in YÖKSİS.
Records
- 2023 Moleküler Yaklaşımla Yaşam Koçluğu
- 2024 HGF Promoter DATE Region Length in Liver Stellate Cells as a Prognostic Biomarker in Hepatocellular Carcinoma Progression
- Comprehensive Analysis of Fusion Transcripts in HCC: Implications for Gene Expression and Tumor Progression
- Fusion transcripts landscape in hepatocellular carcinoma and potential impact on the expression of fusion partners
- 2024 Olfactor Receptor Gene OR2A4/7 As A Potential Biomarker in Colorectal Cancer
- 2024 Exploring MET-CAV1 Fusion Transcript: A Novel Biomarker Candidate for Patient Stratification for Treatment Response in Hepatocellular Carcinoma
- Involvement of Androgen Receptor/miR-181a-5p/c-Met Axis in the Progression of Prostate Cancer
- 2023 Profiling of the olfactory receptor family expression in colon carcinoma by using in silico approaches
- Caveolin-1 as a modulator of sorafenib resistance in Hepatocellular Carcinoma
- 2023 Profiling of the olfactory receptor family expression in colon carcinoma by using in silico approaches
- Olfactory Receptor OR2A4/7 and its Effects on Epithelial-Mesenchymal Plasticity in Colorectal Cancer
- Profiling of the olfactory receptor family expression in colon carcinoma by using in silico approaches
- 2025 Caveolin-1 contributes to sorafenib resistance by enhancing aggressive phenotype in Hepatocellular Carcinoma
- Liver Microenvironment and Metastatic Potential Drive Transcriptional and Translational Remodeling of Ribosome Biogenesis and RNA Processing in Colorectal Cancer
- miR-181a-5p and Caveolin-1 Express Inversely in HCC and Augment the Aggressive Phenotype of Sorafenib-Resistant HCC Cells
- 2024 miR-181a-5p sensitizes Sorafenib resistance by attenuating the aggressive phenotype by the inverse correlation with Cav-1 in Hepatocellular Carcinoma
- 2023 Caveolin-1 as a modulator of sorafenib resistance in Hepatocellular Carcinoma
- miR-181a-5p/GLS axis: a potential biomarker for sorafenib response in Hepatocellular Carcinoma
- 2024 3D Cell Culture Models as a Platform for Studying Tumor Progression, Testing Treatment Responses, and Discovering Biomarkers
- Olfactory Receptors as Regulators of Aggressive Phenotype in Colorectal Cancer